Business Description
Welgene Biotech Co Ltd
ISIN : TW0006661002
Share Class Description:
ROCO:6661: Ordinary SharesTotal Employee Number:
80Description
Welgene Biotech Co Ltd is engaged in providing genetic and biotechnology testing services and related products. Its offerings include next-generation sequencing (NGS) services, DNA microarray and PCR-based testing solutions, biotechnology reagents, diagnostic products, and laboratory instruments. The company also engages in the trading of medical and biotechnology equipment.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.19 | |||||
Equity-to-Asset | 0.45 | |||||
Debt-to-Equity | 0.8 | |||||
Debt-to-EBITDA | 6.95 | |||||
Interest Coverage | 0.02 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 1.76 | |||||
Beneish M-Score | -2.84 | |||||
WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 5.3 | |||||
3-Year EBITDA Growth Rate | -0.3 | |||||
3-Year EPS without NRI Growth Rate | -53.7 | |||||
3-Year Book Growth Rate | -2.5 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 30.99 | |||||
9-Day RSI | 42.25 | |||||
14-Day RSI | 47.01 | |||||
3-1 Month Momentum % | -13.75 | |||||
6-1 Month Momentum % | -15.12 | |||||
12-1 Month Momentum % | -23.08 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.21 | |||||
Quick Ratio | 1.98 | |||||
Cash Ratio | 1.64 | |||||
Days Inventory | 65.04 | |||||
Days Sales Outstanding | 42.72 | |||||
Days Payable | 33.02 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shareholder Yield % | -7.68 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 41.54 | |||||
Operating Margin % | 0.02 | |||||
Net Margin % | 0.35 | |||||
EBITDA Margin % | 8.66 | |||||
FCF Margin % | -1.8 | |||||
OCF Margin % | 9.38 | |||||
ROE % | 0.47 | |||||
ROA % | 0.24 | |||||
ROIC % | 0.02 | |||||
3-Year ROIIC % | -6.18 | |||||
ROC (Joel Greenblatt) % | 2.59 | |||||
ROCE % | 1.15 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 292.5 | |||||
PE Ratio without NRI | 358.17 | |||||
Shiller PE Ratio | 21.69 | |||||
Price-to-Owner-Earnings | 26.35 | |||||
PS Ratio | 1.09 | |||||
PB Ratio | 1.45 | |||||
Price-to-Tangible-Book | 1.46 | |||||
Price-to-Operating-Cash-Flow | 11.62 | |||||
EV-to-EBIT | 78.1 | |||||
EV-to-EBITDA | 11.4 | |||||
EV-to-Revenue | 0.99 | |||||
EV-to-FCF | -56.31 | |||||
Price-to-GF-Value | 0.59 | |||||
Price-to-Projected-FCF | 1.16 | |||||
Price-to-Graham-Number | 4.82 | |||||
| Price-to-Net-Current-Asset-Value | 17.91 | |||||
Earnings Yield (Greenblatt) % | 1.28 | |||||
FCF Yield % | -1.65 | |||||
Forward Rate of Return (Yacktman) % | -6.81 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Welgene Biotech Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 375.94 | ||
| EPS (TTM) (NT$) | 0.06 | ||
| Beta | -0.0593 | ||
| 3-Year Sharpe Ratio | -0.42 | ||
| 3-Year Sortino Ratio | -0.65 | ||
| Volatility % | 21.25 | ||
| 14-Day RSI | 47.01 | ||
| 14-Day ATR (NT$) | 0.693301 | ||
| 20-Day SMA (NT$) | 18.0925 | ||
| 12-1 Month Momentum % | -23.08 | ||
| 52-Week Range (NT$) | 15.5 - 24.05 | ||
| Shares Outstanding (Mil) | 23.3 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Welgene Biotech Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Welgene Biotech Co Ltd Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| 1.08:1 Stock Split | 2018-08-17 | 21.20 (+0.00%) |
Show
Entries
Welgene Biotech Co Ltd Frequently Asked Questions
What is Welgene Biotech Co Ltd(ROCO:6661)'s stock price today?
The current price of ROCO:6661 is NT$17.55. The 52 week high of ROCO:6661 is NT$24.05 and 52 week low is NT$15.50.
When is next earnings date of Welgene Biotech Co Ltd(ROCO:6661)?
The next earnings date of Welgene Biotech Co Ltd(ROCO:6661) is .
Does Welgene Biotech Co Ltd(ROCO:6661) pay dividends? If so, how much?
Welgene Biotech Co Ltd(ROCO:6661) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Welgene Biotech Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers